❌

Normal view

A New Drug Lifts the Fog of Sleepiness for Those With Narcolepsy

9 September 2026 at 13:21
The first-of-its-kind drug offers a reprieve for people who live with the debilitating sleep disorder.

Β© BSIP/Universal Images Group, via Getty Images

Patients with type 1 narcolepsy experience constant sleepiness and episodes of cataplexy, a sudden loss of muscle control often triggered by happy emotions.

A β€˜Transformative’ Narcolepsy Drug Opens New Opportunities in Neuroscience

9 September 2026 at 08:00
A first-of-its-kind drug for the sleep disorder offers a new treatment for people who live with the debilitating fog of sleepiness.

Β© BSIP/Universal Images Group, via Getty Images

Patients with type 1 narcolepsy experience constant sleepiness and episodes of cataplexy, a sudden loss of muscle control often triggered by happy emotions.

Early Data Indicates an A.I.-Generated Drug Could Slow Aging

7 September 2026 at 11:12
Artificial intelligence was used to help develop a drug candidate, rentosertib, for a rare lung condition. Its maker says the drug also seems to reduce the biological hallmarks of age.

Β© Laurie Chen/Reuters

Rentosertib, Insilico Medicine’s small-molecule drug candidate developed and designed using generative A.I. for treating chronic lung disease, at the company’s research and development facility in Shanghai.

The Heart Drug Pelacarsen Fails, Shocking Novartis and Cardiologists

4 September 2026 at 19:42
Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new tool to fight heart disease.

Β© Juan Gaertner/Science Source

An illustration of lipoprotein(a), a low-density lipoprotein. Every study short of a randomized clinical trial had indicated that the drug would lower Lp(a) and help protect people from heart disease.
❌